These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 32573845)

  • 1. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
    Kanzaki R; Pietras K
    Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15
    Dominguez CX; Müller S; Keerthivasan S; Koeppen H; Hung J; Gierke S; Breart B; Foreman O; Bainbridge TW; Castiglioni A; Senbabaoglu Y; Modrusan Z; Liang Y; Junttila MR; Klijn C; Bourgon R; Turley SJ
    Cancer Discov; 2020 Feb; 10(2):232-253. PubMed ID: 31699795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
    Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
    Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CAFs to overcome anticancer therapeutic resistance.
    Saw PE; Chen J; Song E
    Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
    Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.
    Jenkins BH; Buckingham JF; Hanley CJ; Thomas GJ
    Pharmacol Ther; 2022 Dec; 240():108231. PubMed ID: 35718294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search of definitions: Cancer-associated fibroblasts and their markers.
    Nurmik M; Ullmann P; Rodriguez F; Haan S; Letellier E
    Int J Cancer; 2020 Feb; 146(4):895-905. PubMed ID: 30734283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer.
    Dai S; Liu Y; Liu Z; Li R; Luo F; Li Y; Dai L; Peng X
    Pharmacol Res; 2024 Aug; 206():107304. PubMed ID: 39002870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors.
    Leask A
    Semin Cell Dev Biol; 2020 May; 101():111-114. PubMed ID: 31708414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
    Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
    Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
    Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
    Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity and Biology of Cancer-Associated Fibroblasts.
    Biffi G; Tuveson DA
    Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co-expression network analysis.
    Xu Y; Zhang Z; Zhang L; Zhang C
    Breast Cancer; 2020 Sep; 27(5):1017-1028. PubMed ID: 32383139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta.
    Aboulkheyr Es H; Zhand S; Thiery JP; Warkiani ME
    Integr Biol (Camb); 2020 Jul; 12(7):188-197. PubMed ID: 32638026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death.
    Cheteh EH; Augsten M; Rundqvist H; Bianchi J; Sarne V; Egevad L; Bykov VJ; Östman A; Wiman KG
    Cell Death Dis; 2017 Jun; 8(6):e2848. PubMed ID: 28569790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.